semaglutide advisory committee Thousands of lawsuits have been filed against Novo Nordisk over its diabetes and weight-loss drug Ozempic and related GLP-1 medications. As of early 2026, estimates suggest that roughly 2,800 to around 3,000 As negotiations are underway for

Evidence-backed comparison of psyllium vs GLP-1s, trial results, and practical guidance to help you choose the right path

GLP-1 patches are popping up everywhere online, promising needle-free weight loss support and an easy alternative to injections

Diabetic ketoacidosis (DKA) presents a severe complication of diabetes mellitus (DM), characterized by elevated blood sugar levels, metabolic acidosis, and ketosis

Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the brand name Ozempic

After reviewing several large epidemiological studies, clinical trial and in-market data, EMAs Pharmacovigilance Risk Assessment Committee has concluded non-anterior ischemic optic neuropathy is a very rare side effect of Ozempic, that may affect up to one in 10,000 people taking semaglutide.